✦ LIBER ✦

History of maternal fetal loss and increased risk of childhood acute leukemia at an early age. A report from the childrens cancer group

✍ Scribed by Mark W. Yeazel; William G. Woods; Leslie L. Robison; Jonathan D. Buckley; Kathy Ruccione

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 881 KB
Volume: 75
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19950401)75:7<1718::aid-cncr2820750725>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maternal drug use and risk of childhood

Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the childrens cancer study group)

✍ Leslie L. Robison; Jonathan D. Buckley; Anne E. Daigle; Robert Wells; Denis Benj 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

Disappearance of the predictive value of

Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: A report from childrens cancer study group

✍ Harland Sather; Peter Coccia; Mark Nesbit; Carolyn Level; Denman Hammond 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB

Reproductive history, infertility treatm

Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome : A Report From the Children's Oncology Group

✍ Susan E. Puumala; Julie A. Ross; Andrew F. Olshan; Leslie L. Robison; Franklin O 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## BACKGROUND. Children with Down syndrome (DS) have from 10 to 20 times the risk of developing acute leukemia than the general pediatric population. There is mixed evidence for associations between reproductive history or infertility and acute leukemia among children without DS. ## M

Comparison of idarubicin to daunomycin i

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group

✍ Feig, Stephen A.; Ames, Matthew M.; Sather, Harland N.; Steinherz, Laurel; Reid, 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 1003 KB

The outcome of children with acute lymphoblastic leukemia (ALL) and bone marrow relapse has been unsatisfactory largely because of failure to prevent subsequent leukemia relapses. Ninety-six patients were enrolled and received vincristine, prednisone, L-asparaginase, and an anthracycline as reinduc

Treatment of high-risk acute lymphoblast

Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan

✍ Matsuzaki, Akinobu; Ishii, Eiichi; Okamura, Jun; Eguchi, Haruhiko; Yoshida, Nobu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985( -1988( ) and ALHR88 (1988( -1990)). All patients received induction therapy consisting of vincristine (VCR), prednisolone (PSL),